Physician profile
Robert M Alexander
NPI 1841724366
$485.89
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.79 · 2021: $38.96 · 2023: $312 · 2024: $93.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $85.84 | 2023-2024 | |
| Glaxosmithkline, LLC. | $57.98 | 2023-2024 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $51.02 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $50.00 | 2023 | Veozah, Myrbetriq |
| Medtronic, INC. | $44.48 | 2023-2024 | Intellis Adaptivestim |
| Pfizer INC. | $35.05 | 2023 | |
| Merck Sharp & Dohme LLC | $32.58 | 2021-2023 | Belsomra |
| Biohaven Pharmaceuticals, INC. | $19.47 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.48 | 2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $17.35 | 2023 | |
| Lilly USA, LLC | $17.29 | 2023 | Mounjaro |
| Abbott Laboratories | $17.10 | 2019 | |
| Sanofi Pasteur INC. | $15.56 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.81 | 2019 | |
| Ironwood Pharmaceuticals, INC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.